Financials
Income statement
| Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
|---|---|---|---|---|
| Total reported revenue | 2.4B | 2.4B | 2.3B | 2.2B |
| Cost of revenue | 992.9M | 1.0B | 1.0B | 979.0M |
| Gross profit | 1.4B | 1.4B | 1.3B | 1.2B |
| Operating expense | ||||
| Research & development | 402.9M | 378.9M | 362.7M | 354.9M |
| Selling general and admin | 284.8M | 277.2M | 257.2M | 244.1M |
| Other operating expenses | — | — | — | — |
| Operating income | 555.2M | 572.3M | 503.6M | 392.1M |
| Non operating interest income | ||||
| Income | 23.5M | 27.9M | 26.4M | 15.3M |
| Expense | 75.3M | 82.8M | 85.2M | 77.1M |
| Other income expense | -67.8M | -1.1M | -21.9M | -5.7M |
| Pretax income | 435.6M | 516.3M | 423.0M | 324.6M |
| Tax provision | 44.3M | 38.3M | 30.8M | 22.4M |
| Net income | 391.3M | 478.1M | 392.2M | 302.2M |
| Basic EPS | 0.8 | 1.0 | 0.8 | 0.6 |
| Diluted EPS | 0.8 | 1.0 | 0.8 | 0.6 |
| Basic average shares | 496.1M | 496.4M | 496.3M | 496.1M |
| Diluted average shares | 498.7M | 498.7M | 498.8M | 498.5M |
| EBITDA | 1.1B | 1.1B | 1.1B | 936.0M |
| Net income from continuing op. | 391.3M | 478.1M | 392.2M | 302.2M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |